Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/06/2003WO2003090775A1 Foods and drugs containing silkworm and wild silkworm silk powder for antidementia effect and improving memorization learning
11/06/2003WO2003090774A1 Mannose binding lectin and uses thereof
11/06/2003WO2003090771A2 Diagnostics and therapeutics for diseases associated with trace amine receptor 3(ta3)
11/06/2003WO2003090765A1 Medicinal compositions containing phtocrosslinkable chitosan derivative
11/06/2003WO2003090755A1 Treatment of hypertension in women receiving hormone replacement therapy
11/06/2003WO2003090727A1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
11/06/2003WO2003090720A1 High drug load tablet
11/06/2003WO2003090719A1 Histidine copolymer and methods for using same
11/06/2003WO2003090705A1 Biologically active compounds for the modification of bodily odours
11/06/2003WO2003090703A1 Oral care products containing ovomucin
11/06/2003WO2003090695A2 TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
11/06/2003WO2003090689A2 Neurodegenerative disorder treatment using gdnf secreting neural cells
11/06/2003WO2003090688A2 Enhancement of human epidermal melanogenesis
11/06/2003WO2003090687A2 Using heat shock proteins to increase immune response
11/06/2003WO2003090686A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/06/2003WO2003090685A2 Methods for stimulating tlr/irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
11/06/2003WO2003090682A2 Treatment and prevention of pulmonary conditions
11/06/2003WO2003090675A2 Methods and compositions useful for treating prostate cancer
11/06/2003WO2003090662A2 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/06/2003WO2003090599A2 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/06/2003WO2003090598A2 Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/06/2003WO2003076458A3 Selective dipeptide inhibitors of kallikrein
11/06/2003WO2003072705A3 Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina)
11/06/2003WO2003062269A3 Corticotropin releasing factor receptor 2 agonists
11/06/2003WO2003061556A3 Ingestible capsaicin neutralizer
11/06/2003WO2003057007A3 System for monitoring bacterial tumor treatment
11/06/2003WO2003055983A3 Targeted retrograde gene delivery to motor neurons
11/06/2003WO2003054153A3 Apyrase polypeptides and nucleic acids encoding same
11/06/2003WO2003054009A3 Apoptotically active peptides
11/06/2003WO2003053999A3 Selective arylguanidine peptides as urokinase inhibitors
11/06/2003WO2003052124A3 Screening method for agents useful in treating diabetes
11/06/2003WO2003049694A3 Methods of therapy for non-hodgkin's lymphoma
11/06/2003WO2003046570A3 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
11/06/2003WO2003043486A3 Matrix for the production of tissue engineered ligaments, tendons and other tissue
11/06/2003WO2003040328A3 Antisense modulation of thyroid hormone receptor interactor 6 expression
11/06/2003WO2003039455A3 Methods of treating endometreosis
11/06/2003WO2003038112A3 A composition and method to alter lean body mass and bone properties in a subject
11/06/2003WO2003038036A3 Rescue of gonadotropin releasing hormone receptor mutants
11/06/2003WO2003035004A3 Immunotherapy for reversing immune suppression
11/06/2003WO2003033011A3 Repetitive motifs from salivary proline rich proteins, mucin and collagen
11/06/2003WO2003032901A3 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003030613A3 Methods of treating liver fibrosis and hepatitis c virus infection
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003027237A3 Method of modulating or examining ku70 levels in cells
11/06/2003WO2003025147A3 Novel polynucleotides and proteins encoded thereby
11/06/2003WO2003018049A3 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
11/06/2003WO2003016515A3 Regulation of human glycerol-3-phosphate acyltransferase-like protein
11/06/2003WO2003015714A3 Compositions and therapeutic methods for viral infection
11/06/2003WO2003012031A3 Antisense modulation of stearoyl-coa desaturase expression
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003011327A3 Secretin for the treatment of asthma
11/06/2003WO2003009804A3 Conformationally constrained parathyroid hormone (pth) analogs
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003WO2003006496A3 Protein variants of neocarzinostatine and its homologues and their use
11/06/2003WO2003004064A3 Products for treating ovarian cancers and for preventing relapses
11/06/2003WO2003002061A3 Compositions and methods for treating atherosclerosis
11/06/2003WO2003001983A3 Methods for diagnosing and treating a disease mediated by decreased mmp-2 function
11/06/2003WO2002102318A3 Eglin c based drugs for treatment of disease
11/06/2003WO2002098916A3 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
11/06/2003WO2002095008A3 Methods of modulating surfactant phospholipid production
11/06/2003WO2002085934A3 Antibacterial peptides, compositions containing same and uses thereof
11/06/2003WO2002081641A3 Gene scc-112 and diagnostic and therapeutic uses thereof
11/06/2003WO2002080960A3 Treatment of neuropathologies associated with expression of tnf-alpha
11/06/2003WO2002079401A3 Novel rgs9 protein binding interactions and methods of use thereof
11/06/2003WO2002079386A3 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof
11/06/2003WO2002079242A3 Adp-ribosylating bacterial toxins
11/06/2003WO2002076482B1 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002068648A3 Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002061066A8 Method for producing an enzyme from a novel source
11/06/2003WO2002060949A8 Glycoforms a fas ligand inhibitory protein analog
11/06/2003WO2002060947A8 Glycoforms a fas ligand inhibitory protein analog
11/06/2003WO2002060491A3 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002059117A8 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
11/06/2003WO2002059108A8 Melanocortin receptor agonists
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002050247A3 Antisense modulation of hepsin expression
11/06/2003WO2002045708A9 Use of zwitterionic polysaccharides for the specific modulation of immune processes
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002044199A3 Neurotoxins with enhanced target specificity
11/06/2003WO2002030257A3 Normalization of defective t cell responsiveness through manipulation of thymic regeneration
11/06/2003WO2002026785A3 Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
11/06/2003WO2002024750A3 Human kidney tumor overexpressed membrane protein 1
11/06/2003WO2002022138A9 Antibacterial agents and methods of identification
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003WO2002012276A3 Pleckstrin homology polypeptides and dna encoding such
11/06/2003WO2002009639A3 Methods and pharmaceutical compositions for healing wounds
11/06/2003WO2002005749A3 Crf2 ligands in combination therapy
11/06/2003WO2002004952A3 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
11/06/2003WO2001090157A8 98p7c3: homeodomain protein highly expressed in various cancers
11/06/2003WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
1 ... 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 ... 3163